Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar protein sorting-associated protein 33A (VPS33A) is a member of the Sec1/Munc18 (SM) protein family and serves as a core component of both the CORVET and HOPS multisubunit tethering complexes, which are essential regulators of endosomal trafficking and vesicle fusion in mammalian cells. VPS33A interacts specifically with VPS16 and forms part of a four-protein "class C core" within both CORVET (for early endosomes) and HOPS (for late endosomes and autolysosomes), mediating the tethering and SNARE-dependent fusion of endosomes, lysosomes, and autophagosomes. VPS33A is critical for correct vesicle targeting, fusion, and maintenance of cellular homeostasis, with loss-of-function mutations resulting in severe trafficking and metabolic disorders, including newly described diseases with mucopolysaccharidosis-like symptoms. VPS33A is evolutionarily conserved, not directly a drug target, but is essential for fundamental membrane trafficking functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting-associated protein 33A (VPS33A).